These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 12174893

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
    Virgolini I, Szilvasi I, Kurtaran A, Angelberger P, Raderer M, Havlik E, Vorbeck F, Bischof C, Leimer M, Dorner G, Kletter K, Niederle B, Scheithauer W, Smith-Jones P.
    J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
    Hofland LJ, Lamberts SW, van Hagen PM, Reubi JC, Schaeffer J, Waaijers M, van Koetsveld PM, Srinivasan A, Krenning EP, Breeman WA.
    J Nucl Med; 2003 Aug; 44(8):1315-21. PubMed ID: 12902423
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tecnetium-99m as alternative to produce somatostatin-labeled derivatives: comparative biodistribution evaluation with 111In-DTPA-octreotide.
    Melo IB, Ueda LT, Araujo EB, Muramoto E, Barboz MF, Mengatti J, Buchpiguel CA, Silva CP.
    Cell Mol Biol (Noisy-le-grand); 2010 May 10; 56(2):31-6. PubMed ID: 20525456
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake.
    Kwekkeboom DJ, Kooij PP, Bakker WH, Mäcke HR, Krenning EP.
    J Nucl Med; 1999 May 10; 40(5):762-7. PubMed ID: 10319747
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs.
    Dörr U, Wurm K, Höring E, Guzman G, Räth U, Bihl H.
    Horm Metab Res Suppl; 1993 May 10; 27():36-43. PubMed ID: 8330870
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sandostatin labeled with 99mTc: in vitro stability, in vivo validity and comparison with 111In-DTPA-octreotide.
    Kolan H, Li J, Thakur ML.
    Pept Res; 1996 May 10; 9(3):144-50. PubMed ID: 8875594
    [Abstract] [Full Text] [Related]

  • 19. Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes.
    Duncan JR, Stephenson MT, Wu HP, Anderson CJ.
    Cancer Res; 1997 Feb 15; 57(4):659-71. PubMed ID: 9044843
    [Abstract] [Full Text] [Related]

  • 20. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides.
    Vallabhajosula S, Moyer BR, Lister-James J, McBride BJ, Lipszyc H, Lee H, Bastidas D, Dean RT.
    J Nucl Med; 1996 Jun 15; 37(6):1016-22. PubMed ID: 8683294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.